H-1B sponsorship profile: UNITED PHARMA TECHNOLOGIES, INC. Across U.S. Department of Labor LCA disclosures, UNITED PHARMA TECHNOLOGIES, INC filed 225 Labor Condition Applications covering 225 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 90.7% (204 certified of 225 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on UNITED PHARMA TECHNOLOGIES, INC’s H-1B petitions range from $62,400 at the low end to $176,800 at the high end, with a petition-weighted average of $98,517. That range reflects the mix of occupations the company sponsors, led by Validation Engineer (67 petitions at $93,939 avg), followed by VALIDATION ENGINEER and Process Validation Engineer. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. UNITED PHARMA TECHNOLOGIES, INC is headquartered in SOUTH PLAINFIELD, NJ under NAICS code 54199, and places H-1B workers across 21 states, most heavily in NY, NJ, TX. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.